HANNAH SMITH: Open Payments
NPI 1386068708 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 40 payments from 14 companies in 2025. Trend: 2023 $765 · 2024 $1,200 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $190 |
| Sumitomo Pharma America, Inc. | 9 | $159 |
| UROGEN PHARMA, INC. | 5 | $95 |
| Dendreon Pharmaceuticals LLC | 2 | $69 |
| Endo USA, Inc. | 2 | $49 |
| 180 Medical, Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Verity Pharmaceuticals Inc. | 3 | $44 |
| PFIZER INC. | 2 | $37 |
| TOLMAR, INC. | 2 | $33 |
Products named: ERLEADA, GEMTESA, ORGOVYX, PROVENGE, AVEED, GENTLECATH GLIDE, XTANDI, JATENZO.
Industry payments across AL — which companies pay providers there.
